Arbutus Biopharma (LTS:0SGC) Accounts Payable : $2.32 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arbutus Biopharma Accounts Payable?

Arbutus Biopharma's Accounts Payable for the quarter that ended in Dec. 2024 was $2.32 Mil.

Arbutus Biopharma's quarterly Accounts Payable declined from Jun. 2024 ($2.65 Mil) to Sep. 2024 ($2.32 Mil) but then increased from Sep. 2024 ($2.32 Mil) to Dec. 2024 ($2.32 Mil).

Arbutus Biopharma's annual Accounts Payable declined from Dec. 2022 ($3.52 Mil) to Dec. 2023 ($3.22 Mil) and declined from Dec. 2023 ($3.22 Mil) to Dec. 2024 ($2.32 Mil).

Arbutus Biopharma Accounts Payable Historical Data

The historical data trend for Arbutus Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma Accounts Payable Chart

Arbutus Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

2.99

3.17

3.52

3.22

2.32

Arbutus Biopharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable	Get a 7-Day Free Trial															3.22	3.74	2.65	2.32	2.32

Arbutus Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Arbutus Biopharma Accounts Payable Related Terms

Thank you for viewing the detailed overview of Arbutus Biopharma's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbutus Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (LTS:0SGC) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ABUS:USA I9DN:Germany I9DN:Germany

Address

701 Veterans Circle, Warminster, PA, USA, 18974

Website

http://www.arbutusbio.com

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Arbutus Biopharma Headlines

No Headlines